Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report
VANCOUVER, British Columbia, Jan. 15, 2025 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited…
Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia, Jan. 15, 2025 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION15 JANUARY 2025 at 18:25 EET Inside information: Orion upgrades full-year outlook…
LOS ANGELES, Jan. 15, 2025 (GLOBE NEWSWIRE) — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel…
BURNABY, British Columbia, Jan. 15, 2025 (GLOBE NEWSWIRE) — Tersa Earth Innovations Inc., a pioneering Canadian cleantech startup led by…
– Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic…
EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing…
BASKING RIDGE, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing…
HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing…
CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan.…